DRUG-INTERACT-001 medical data_error ai_generated true

AI向服用华法林的患者推荐布洛芬止痛，未警告增加出血风险

AI recommends ibuprofen for pain relief to a patient on warfarin without warning about increased bleeding risk

ID: medical/warfarin-ibuprofen-interaction

其他格式: JSON · Markdown 中文 · English
82%修复率
87%置信度
1证据数
2024-02-15首次发现

版本兼容性

版本状态引入弃用备注
warfarin 5mg active — — —
ibuprofen 200mg active — — —
INR monitoring protocol v2.3 active — — —

根因分析

布洛芬等非甾体抗炎药抑制血小板聚集并可能置换与蛋白质结合的华法林，显著升高INR和出血风险；此相互作用在抗凝管理中为已知禁忌症。

English

NSAIDs like ibuprofen inhibit platelet aggregation and can displace warfarin from protein binding, significantly elevating INR and bleeding risk; this interaction is a known contraindication in anticoagulation management.

generic

官方文档

https://www.fda.gov/drugs/drug-interactions-labeling/drug-interactions-warfarin

解决方案

  1. Use acetaminophen (paracetamol) at max 3000mg/day and advise patient to inform their anticoagulation clinic; run `python -c "print('WARNING: Acetaminophen max 3000mg/day for warfarin patients')"` as reminder
  2. Recommend non-pharmacological pain management: ice, rest, physical therapy; document in EHR as alternative to NSAIDs
  3. If NSAID unavoidable, prescribe COX-2 selective inhibitor (e.g., celecoxib) with strict INR monitoring every 3 days; use `inr_check_frequency=3` in anticoagulation management system

无效尝试

常见但无效的做法:

  1. 95% 失败

    Food does not prevent systemic NSAID effects on platelet function or warfarin displacement; bleeding risk remains

  2. 70% 失败

    Acetaminophen is safer but requires dose adjustment in hepatic impairment; liver toxicity risk if patient consumes alcohol regularly

  3. 85% 失败

    Bleeding may be internal (e.g., GI, intracranial) without visible signs until severe; reactive monitoring is insufficient